Pharmaceuticals

Small Molecule Drug Discovery Industry Anticipated to Expand at 11.4% CAGR During the Forecast Period

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Small Molecule Drug Discovery Market Between 2025 And 2029?

The small molecule drug discovery market has experienced robust expansion in recent years. This market is projected to increase its value from $62.44 billion in 2024 to $67.94 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.8%. The historical growth of this market can be attributed to various factors, including drug repurposing initiatives, the increasing adoption of automation in drug discovery processes, heightened investment in research and development, supportive regulatory frameworks for drug development, and advancements in high-throughput screening.

The small molecule drug discovery market is anticipated to experience significant expansion over the coming years. This market is projected to reach $104.6 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.4%. Factors contributing to this growth during the forecast period include the rise of new therapeutic targets, a focus on patient-centric drug discovery, the development of drug-device combination products, the application of real-world evidence, the incorporation of pharmacogenomics, and ongoing global health challenges. Key trends for the forecast period encompass fragment-based drug discovery, the integration of artificial intelligence into drug discovery processes, the advancement of RNA-targeted therapeutics, increased collaborations and partnerships, innovations in drug delivery methods, and the growing adoption of organoids and 3D cell culture models.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

What Are The Drivers Pushing New Developments In The Small Molecule Drug Discovery Market?

The increasing occurrence of chronic diseases is projected to stimulate the expansion of the small molecule drug discovery market in the future. Chronic diseases are identified as ailments that persist for a year or longer, interfere with daily activities, require continuous medical attention, or both. Small-molecule drugs can be utilized to manage chronic conditions like HIV, cancer, infections, heart disease, and renal disease, typically offering a more cost-effective option for patients with these long-term health issues. Thus, the growing prevalence of chronic diseases is expected to energize the small molecule drug discovery market. For instance, according to a report published by the National Institutes of Health (NIH), a US-based biomedical research agency, in 2023, in the United States, the population aged 50 and above with at least one chronic illness is anticipated to increase by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Furthermore, the number of individuals experiencing multimorbidity is predicted to rise by 91.16%, from 7.8304 million in 2020 to 14.968 million in 2050. Therefore, the escalating incidence of chronic diseases is a key factor driving the growth of the small molecule drug discovery market.

What Are The Key Segments In The Small Molecule Drug Discovery Market?

The small molecule drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule Drugs, Biologic Drugs

2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others

3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others

4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization

5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others

Subsegments:

1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs

2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies

Which Competitive Trends Are Defining The Small Molecule Drug Discovery Market Structure?

Technological advancements are emerging as a pivotal trend gaining significant traction within the small molecule drug discovery market. Prominent companies active in the small molecule drug discovery market are prioritizing the creation of novel products. For example, in January 2023, Dotmatics, a US-based digital science platform provider, unveiled its Small Molecule Drug Discovery Solution. This offering is distinctively crafted with an integrated scientific research and development platform that incorporates pre-configured workflows and expanded data management functionalities, thereby mitigating operational inefficiencies and expediting the transition of data from insights to actionable decisions.

Which Industry Leaders Are Driving Innovation Across The Small Molecule Drug Discovery Market?

Major companies operating in the small molecule drug discovery market include Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Clinuvel Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Pharmacosmos, Allarity Therapeutics, Xellia Pharmaceuticals, Cyteir Therapeutics, BigHat Biosciences

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

How Do Regional Market Performances Compare Within The Small Molecule Drug Discovery Industry?

North America was the largest region in the small molecule drug discovery market in 2024. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Small Molecule Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9834&type=smp

Browse Through More Reports Similar to the Global Small Molecule Drug Discovery Market 2025, By The Business Research Company

Cardiovascular Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795